RESEARCH-USE BIOSIMILAR ANTIBODY
Tamtuvetmab
Monoclonal antibody · IgG2
Tamtuvetmab (AT-005) is a caninised blontuvetmab against CD52. Tamtuvetmab increases progression-free survival (PFS), exhibits in vivo efficacy in dogs with naïve T-cell lymphoma (LSA). Tamtuvetmab has been approved by veterinary.
TARGETCD52
YMonoclonal antibody
CATALOGSC-BS-130
CATALOG NUMBERSC-BS-130
MOLECULAR WEIGHTApprox. 146.346 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Tamtuvetmab (AT-005) is a caninised blontuvetmab against CD52. Tamtuvetmab increases progression-free survival (PFS), exhibits in vivo efficacy in dogs with naïve T-cell lymphoma (LSA). Tamtuvetmab has been approved by veterinary.
Tamtuvetmab is a recombinant research-use antibody directed against CD52.